Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy.
Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.
Catheter Cardiovasc Interv. 2021 May 1;97(6):E789-E800. doi: 10.1002/ccd.29425. Epub 2020 Dec 17.
The role of the target vessel in percutaneous revascularization of chronic total occlusion (CTO) is unclear.
We sought to assess the long-term results of percutaneous coronary intervention (PCI) for CTO lesions in each coronary artery and to investigate the impact of successful revascularization and previous myocardial infarction (MI) in the territory of the target vessel.
Cohort observational study on 1,124 patients who have undergone CTO PCI attempt: 371 on left anterior descending artery (LAD), 485 right coronary artery, and 268 left circumflex. Patients were further stratified by successfully revascularized and not-revascularized CTO (CTO-NR). Vessels affected by a previous MI were defined as infarct-related artery (IRA). The primary endpoint was cardiac death; the secondary endpoint was the combined rate of sudden cardiac-death and sustained ventricular-arrhythmias (SCD/SVAs). Propensity score-matching was performed to evaluate LAD versus NON-LAD CTO. Up to 12-year follow-up, the clinical benefit associated with successful PCI was consistent across the three groups. CTO-NR had the greatest association with cardiac death and SCD/SVAs in each coronary artery and in IRA-CTO patients.
Unsuccessful percutaneous CTO revascularization was associated with lower cardiac survival and freedom from SCD/SVAs, irrespective of the vessel treated. This result was mainly driven by patients with an IRA CTO.
经皮血运重建治疗慢性完全闭塞(CTO)病变时靶血管的作用尚不清楚。
我们旨在评估经皮冠状动脉介入治疗(PCI)治疗每支冠状动脉 CTO 病变的长期结果,并探讨成功血运重建和靶血管区域既往心肌梗死(MI)的影响。
这是一项对 1124 例接受 CTO-PCI 尝试的患者进行的队列观察性研究:左前降支(LAD)371 例,右冠状动脉 485 例,左回旋支 268 例。患者进一步根据成功血运重建和未血运重建的 CTO(CTO-NR)进行分层。既往发生 MI 的血管被定义为梗死相关动脉(IRA)。主要终点为心源性死亡;次要终点为心源性猝死和持续性室性心律失常(SCD/SVAs)的联合发生率。采用倾向评分匹配评估 LAD 与非 LAD CTO。在 12 年的随访中,成功 PCI 与临床获益相关,在三支冠状动脉和 IRA-CTO 患者中均保持一致。CTO-NR 与每支冠状动脉和 IRA-CTO 患者的心脏死亡和 SCD/SVAs 的发生率最高。
经皮 CTO 血运重建不成功与较低的心脏生存率和免于 SCD/SVAs 相关,与治疗的血管无关。这一结果主要归因于 IRA-CTO 患者。